Neuroprotection against hypoxic/hypoglycaemic injury after the insult by the group III metabotropic glutamate receptor agonist (R,S)-4-phosphonophenylglycine

British Journal of Pharmacology

Volumn 131, Issue 4, 2000, Pages 655-658

  Sabelhaus, Clemens F ^a   Schröder, Ulrich H ^a   Breder, Jörg ^a   Henrich Noack, Petra ^a   Reymann, Klaus G ^a,b  

^a LEIBNIZ INSTITUTE FOR NEUROBIOLOGY   (Germany)

^b Research Institute for Applied Neurosciences GmbH   (Germany)

Author keywords

(R,S) PPG; Hippocampus; Hypoxia hypoglycaemia; MGluR; Neuroprotection

Indexed keywords

4 PHOSPHONOPHENYLGLYCINE; GLUTAMATE RECEPTOR; GLUTAMATE RECEPTOR AGONIST; GLUTAMIC ACID; GLYCINE DERIVATIVE; METABOTROPIC RECEPTOR; NEUROTRANSMITTER; UNCLASSIFIED DRUG;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN DEGENERATION; BRAIN HYPOXIA; BRAIN INJURY; BRAIN SLICE; CONTROLLED STUDY; DRUG EFFECT; DRUG SCREENING; HIPPOCAMPUS; HYPOGLYCEMIA; MALE; NEUROPROTECTION; NEUROTRANSMITTER RELEASE; NONHUMAN; PRIORITY JOURNAL; RAT; SYNAPTIC TRANSMISSION;

EID: 0035223902     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0703646     Document Type: Article

References (20)

1. ABDUL-GHANI, A., ATTWELL, P.J.E., SING KENT, N., BRADFORD, H.F., CROUCHER, M.J. & JANE, D.E. (1997). Anti-epileptogenic and anticonvulsant activity of L-2-amino-4-phosphonobutyrate, a presynaptic glutamate receptor agonist. Brain Res., 755, 202-212.
2. BIGGE, C.F., DRUMMOND, J.T., JOHNSON, G., MALONE, T., PROBERT, JR., A.W., MARCOUX, F.W., COUGHENOUR, L.L. & BRABES, L.J. (1989). Exploration of phenyl-spaced 2-amino-(5-9)-phosphonoalkanoic acids as competitive N-methyl-D-aspartatic acid antagonists. J. Med. Chem., 32, 1580-1590.
3. BOND, A., O'NEILL, M.J., HICKS, C.A., MONN, J.A. & LODGE, D. (1998). Neuroprotective effects of a systemically active group II metabotropic glutamate receptor agonist LY354740 in a gerbil model of global ischaemia. NeuroReport, 9, 1191-1193.
4. BRADLEY, S.R., LEVEY, A.I., HERSCH, S.M. & CONN, P.J. (1996). Immunocytochemical localization of group III metabotropic glutamate receptors in the hippocampus with subtype specific antibodies. J. Neurosci., 16, 2044-2056.
5. BRUNO, V., BATTAGLIA, G., KINGSTON, A., O'NEILL, M.J., CATANIA, M.V., DI GREZIA, R. & NICOLETTI, F. (1999). Neuroprotective activity of the potent and selective mGlu1a metabotropic glutamate receptor antagonist, (+)-2-methyl-4-carboxyphenylglycine (LY367385): comparison with LY357366, a broader spectrum antagonist with equal affinity for mGlu1a and mGlu5 receptors. Neuropharmacology, 38, 199-207.
6. COPANI, A., BRUNO, V., BATTAGLIA, G., LEANZA, G., PELLITTERI, R., RUSSO, A., STANZANI, S. & NICOLETTI, F. (1995). Activation of metabotropic glutamate receptors protects cultured neurones against apoptosis induced by beta-amyloid peptide. Mol. Pharmacol., 47, 890-897.
7. FADEN, A.I., IVANOVA, S.A., YAKOVLEV, A.G. & MUKHIN, A.G. (1997). Neuroprotective effects of group III mGluR in traumatic neuronal injury. J. Neurotrauma, 14, 885-895.
8. GASPARINI, F., BRUNO, V., BATTAGLIA, G., LUKIC, S., LEONHARDT, T., INDERBITZIN, W., LAURIE, D., SOMMER, B., VARNEY, M.A., HESS, S.D., JOHNSON, E.C., KUHN, R., URWYLER, S., SAUER, D., PORTRET, C., SCHMUTZ, M., NICOLETTI, F. & FLOR, P.J. (1999). (R,S)-4-Phosphonophenylglycine, a potent and selective group III metabotropic glutamate receptor agonist, is anticonvulsive and neuroprotective in vivo. J. Pharmacol. Exp. Ther., 290, 1678-1687.
9. GRAHAM, M.E. & BURGOYNE, R.D. (1994). Activation of metabotropic glutamate receptors by L-AP4 stimulates survival of rat ccrebellar granule cells in culture. Eur. J. Pharmacol., 288, 115-123.
10. HENRICH-NOACK, P., HATTON, C.D. & REYMANN, K.G. (1998). The mGlu receptor ligand (S)-4C3HPG protects neurones after global ischaemia in gerbils. Neuroreport, 9, 985-988.
11. LOMBARDI, G., ALESIANI, M., LEONARDI, P., CHERIZI, G., PELLICCIARI, R. & MORONI, F. (1993). Pharmacological characterization of the metabotropic glutamate receptor inhibiting the D-[(3)H]-aspartate output in rat striatum. Br. J. Pharmacol., 110, 1407-1412.
12. MAIESE, K., SWIRIDUK, M. & TENBROEKE, M. (1996). Cellular mechanisms of protection by metabotropic glutamate receptors during anoxia and nitric oxide toxicity. J. Neurochem., 66, 2419-2428.
13. MARTIN, G., NIE, Z. & SIGGINS, G.R. (1997). Metabotropic glutamate receptors regulate N-methyl-D-aspartate-mediated synaptic transmission in nucleus accumbens. J. Neurophysiol., 78, 3028-3038.
14. MELDRUM, B.S., SWAN, J.H., LEACH, M.J., MILLAN, M.H., GWINN, R., KADOTA, K., GRAHAM, S.H., CHEN, J. & SIMON, R.P. (1992). Reduction of glutamate release and protection against ischaemic brain damage by BW 1003C87. Brain Res., 593, 1-6.
15. OPITZ. T., RICHTER, P., CARTER, A.J., KOZIKOWSKI, A.P., SHINOZAKI, H. & REYMANN, K.G. (1995). Metabotropic glutamate receptor subtypes differentially influence neuronal recovery from in vitro hypoxia/hypoglycaemia in rat hippocampal slices. Neurosci., 68, 989-1001.
16. PIN, J.P. & DUVOISIN, R. (1995). The metabotropic glutamate receptors: structure and function. Neuropharmacology, 34, 1-26.
17. SCHRÖDER, U.H., OPITZ, T., JÄGER, T., SABELHAUS, C.F., BREDER, J. & REYMANN, K.G. (1999). Protective effect of group I metabotropic glutamate receptor activation against hypoxic/ hypoglycaemic injury in rat hippocampal slices: timing and involvement of protein kinase C. Neuropharmacology, 38, 209-216.
18. SMALL, D.L., MONETTE, R., CHAKRAVARTHY B., DURKIN, J., BARBE, G., MEALING, G., MORLEY, P. & BUCHAN A.M. (1996). Mechanisms of 1S,3R-ACPD-induced neuroprotection in rat hippocampal slices subjected to oxygen and glucose deprivation. Neuropharmacology, 35, 1037-1048.
19. URWYLER, S., LAURIE, D., LOWE, D.A., MEIER, C.L. & MULLER, W. (1996). Biphenyl-derivatives of 2-amino-7-phosphonoheptanoic acid, a novel class of potent competitive N-methyl-D-aspartate receptor antagonist-I. Pharmacological characterization in vitro. Neuropharmacology, 35, 643-654.
20. WIGMORE, M.A. & LACEY, M.G. (1998). Metabotropic glutamate receptors depress glutamate-mediated synaptic input to rat midbrain dopamine neurones in vivo. Br. J. Pharmacol., 123, 667-674.